Dottikon Es Holding AG (DESN) - Total Assets
Based on the latest financial reports, Dottikon Es Holding AG (DESN) holds total assets worth CHF1.39 Billion CHF (≈ $1.76 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Dottikon Es Holding AG (DESN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Dottikon Es Holding AG - Total Assets Trend (2005–2025)
This chart illustrates how Dottikon Es Holding AG's total assets have evolved over time, based on quarterly financial data. See Dottikon Es Holding AG net assets for net asset value and shareholders' equity analysis.
Dottikon Es Holding AG - Asset Composition Analysis
Current Asset Composition (March 2025)
Dottikon Es Holding AG's total assets of CHF1.39 Billion consist of 37.3% current assets and 62.7% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF147.77 Million | 10.9% |
| Accounts Receivable | CHF112.41 Million | 8.3% |
| Inventory | CHF193.96 Million | 14.4% |
| Property, Plant & Equipment | CHF792.03 Million | 58.7% |
| Intangible Assets | CHF2.25 Million | 0.2% |
| Goodwill | CHF0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Dottikon Es Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Dottikon Es Holding AG stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dottikon Es Holding AG's current assets represent 37.3% of total assets in 2025, an increase from 31.2% in 2005.
- Cash Position: Cash and equivalents constituted 10.9% of total assets in 2025, up from 3.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 9.0% in 2005.
- Asset Diversification: The largest asset category is property, plant & equipment at 58.7% of total assets.
Dottikon Es Holding AG Competitors by Total Assets
Key competitors of Dottikon Es Holding AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangxi Ganfeng Lithium Co Ltd
SHE:002460
|
China | CN¥110.20 Billion |
|
Do-Fluoride Chemicals Co Ltd
SHE:002407
|
China | CN¥24.34 Billion |
|
Xinfengming Group Co Ltd
SHG:603225
|
China | CN¥67.08 Billion |
|
Kemira Oyj
HE:KEMIRA
|
Finland | €3.13 Billion |
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568
|
China | CN¥25.67 Billion |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SHE:002145
|
China | CN¥19.62 Billion |
|
Sichuan Development Lomon Co Ltd
SHE:002312
|
China | CN¥21.88 Billion |
|
Guizhou Chanhen Chemical Corp
SHE:002895
|
China | CN¥13.62 Billion |
Dottikon Es Holding AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.94 | 2.38 | 2.73 |
| Quick Ratio | 1.71 | 1.37 | 1.40 |
| Cash Ratio | 0.83 | 0.81 | 0.99 |
| Working Capital | CHF345.35 Million | CHF268.98 Million | CHF116.74 Million |
Dottikon Es Holding AG - Advanced Valuation Insights
This section examines the relationship between Dottikon Es Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.45 |
| Latest Market Cap to Assets Ratio | 3.43 |
| Asset Growth Rate (YoY) | 13.3% |
| Total Assets | CHF1.35 Billion |
| Market Capitalization | $4.63 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Dottikon Es Holding AG's assets at a significant premium (3.43x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Dottikon Es Holding AG's assets grew by 13.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dottikon Es Holding AG (2005–2025)
The table below shows the annual total assets of Dottikon Es Holding AG from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | CHF1.35 Billion ≈ $1.71 Billion |
+13.26% |
| 2024-03-31 | CHF1.19 Billion ≈ $1.51 Billion |
+13.10% |
| 2023-03-31 | CHF1.05 Billion ≈ $1.33 Billion |
+22.80% |
| 2022-03-31 | CHF858.41 Million ≈ $1.09 Billion |
+11.95% |
| 2021-03-31 | CHF766.75 Million ≈ $969.39 Million |
+56.53% |
| 2020-03-31 | CHF489.84 Million ≈ $619.29 Million |
+5.78% |
| 2019-03-31 | CHF463.09 Million ≈ $585.47 Million |
+5.64% |
| 2018-03-31 | CHF438.38 Million ≈ $554.23 Million |
+15.21% |
| 2017-03-31 | CHF380.51 Million ≈ $481.07 Million |
+11.54% |
| 2016-03-31 | CHF341.16 Million ≈ $431.32 Million |
+2.77% |
| 2015-03-31 | CHF331.98 Million ≈ $419.71 Million |
+0.27% |
| 2014-03-31 | CHF331.10 Million ≈ $418.60 Million |
-2.62% |
| 2013-03-31 | CHF339.99 Million ≈ $429.84 Million |
-5.16% |
| 2012-03-31 | CHF358.48 Million ≈ $453.21 Million |
-2.27% |
| 2011-03-31 | CHF366.80 Million ≈ $463.73 Million |
-4.24% |
| 2010-03-31 | CHF383.04 Million ≈ $484.27 Million |
+6.01% |
| 2009-03-31 | CHF361.33 Million ≈ $456.82 Million |
+5.05% |
| 2008-03-31 | CHF343.97 Million ≈ $434.87 Million |
+3.59% |
| 2007-03-31 | CHF332.05 Million ≈ $419.81 Million |
+2.57% |
| 2006-03-31 | CHF323.73 Million ≈ $409.28 Million |
+2.41% |
| 2005-03-31 | CHF316.12 Million ≈ $399.66 Million |
-- |
About Dottikon Es Holding AG
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blo… Read more